Regeneron Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 81 Columbia Turnpike, Rensselaer, New York (NY) 12144, United States (USA)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 1000514603 · DUNS 945589711
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-03-22
- VAIDrug Quality Assurance2021-10-25
- VAIDrug Quality Assurance2019-10-18
- NAIDrug Quality Assurance2017-10-05
- VAIDrug Quality Assurance2016-08-19
- VAIDrug Quality Assurance2014-06-13
- VAIDrug Quality Assurance2013-05-24
- NAIDrug Quality Assurance2012-06-08
- NAIDrug Quality Assurance2011-07-29
- VAIDrug Quality Assurance2010-03-31
Drugs this plant is listed as making
10 distinct drugs across 24 products name this site in their FDA label.
- afliberceptRegeneron Pharmaceuticals, Inc
- alirocumabSanofi-Aventis U.S. LLC
- atoltivimab, maftivimab, and odesivimab-ebgnRegeneron Pharmaceuticals, Inc.
- cemiplimab-rwlcRegeneron Pharmaceuticals, Inc.
- DupilumabSanofi-Aventis U.S. LLC
- linvoseltamab-gcptRegeneron Pharmaceuticals, Inc.
- PozelimabRegeneron Pharmaceuticals, Inc.
- rilonaceptKiniksa Pharmaceuticals (UK), Ltd.
- sarilumabSanofi-Aventis U.S. LLC
- ziv-afliberceptsanofi-aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.